Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company · Oxford

Oxford Drug Design Limited

Research and experimental development on biotechnology

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Oxford Drug Design Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 17

  1. Oliver Robert Lyth 2022-2022 Director View profile
  2. David Ian Ford 2019-2023 Director View profile
  3. Dr Igor Gorin 2017-2018 Director View profile
  4. Paul Jonathan Davie 2010-2012 Director View profile
  5. Andrew James Naylor 2009-2012 Director View profile
  6. Dr Barry Porter 2005-2012 Director View profile
  7. Jussi Pekka Westergren 2005-2009 Director View profile
  8. David Robert Norwood 2001-2005 Director View profile
  9. Dr Herbert Frank Askew 2001-2003 Director View profile
  10. Professor William Graham Richards 2001-2025 Director View profile
  11. Dr Edwin Moses 2001-2002 Director View profile
  12. Wcphd Directors Limited 2001-2001 Corporate-director View profile
  13. Nikki Marie Cooper 2021-2023 Secretary View profile
  14. Haddleton & CO Limited 2020-2021 Corporate-secretary View profile
  15. James Maxwell Parish 2008-2012 Secretary View profile
  16. John Quantrill Davies 2005-2009 Secretary View profile
  17. Wcphd Secretaries Limited 2001-2005 Corporate-secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Research and experimental development on biotechnology
Incorporated
17/10/2001
Registered office
Oxford
Previous names
Inhibox Limited (until 15/05/2017)

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

  • IP2IPO Limited ceased 2019-07-29
    significant influence · notified 2016-04-06

Group

  1. Oxford Drug Design Limited is controlled by IP2IPO Limited
    Evidence
    ceased significant influence · notified 2016-04-06, ceased 2019-07-29 · source: Companies House PSC register
  2. IP2IPO Limited is controlled by IP Group PLC
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register

Ultimately controlled by IP Group PLC.

147 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Financials

Total assets
£438,861
Employees
7
Turnover
Not reported (small or micro-entity accounts)

Figures from accounts filed at Companies House (iXBRL), period ending 2025-12-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.

Grants received

6 grants · £2,878,641 total

360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.

Top funders

  • Department for Business, Energy and Industrial Strategy · £2,808,892 (5 grants)
  • Department for Science, Innovation and Technology · £69,749

Most recent

  • Department for Business, Energy and Industrial Strategy £54,5832022-04-01
  • Department for Science, Innovation and Technology £69,7492022-02-16
  • Department for Business, Energy and Industrial Strategy £68,0742021-12-01
  • Department for Business, Energy and Industrial Strategy £142,1762020-06-01
  • Department for Business, Energy and Industrial Strategy £564,0522019-04-01
Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

5 directors on the board

9.5y median 7.2y
average tenure
23.4y
longest tenure

Directors past 6 years

First-time vs portfolio directors

First-time (2)

Portfolio (3)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 3Dormant 1Health and social care 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Several long-serving directors could step down together
  • Narrow spread of sectors across the board

Where to look Suggested search: succession planning for long-tenured seats; directors from a wider range of sectors.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
04305857
Status
Active
Type
Private Limited Company
Accounts next due
30/09/2027
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data